The prevalence of monogenic PD in Norway is very low, estimated at ~0.5% and virtually accounted for by LRRK2 mutations, based on a population-representative cohort from the region of origin of the majority of our samples (Western Norway)85. The gene discussed is LRRK2; the disease is Parkinson disease.